Skriftligt spörsmål om begränsningen av den expedierade mängden av dyra läkemedel med specialersättning

This question asks about measures to control the costs of expensive medicines that receive special reimbursements. It seeks to understand how the quantity of these medicines can be limited to manage public spending. This concerns patients who rely on specialized medications and the healthcare system's budget. It may impact access to certain treatments and the overall cost of pharmaceutical care.